Skip to main
ALHC
ALHC logo

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc. is strategically positioned to capitalize on the anticipated favorable 2026 Medicare Advantage rate update, especially as many competing Managed Care Organizations are reducing benefits. The company's integrated Medicare Advantage and Value-Based Care model is expected to facilitate long-term market share growth and above-average financial performance. Additionally, projections indicate robust growth in gross profit per member per month (PMPM), with initial cohorts generating $90-$150 PMPM, potentially increasing to over $230 PMPM in subsequent years, further supporting a positive financial outlook.

Bears say

Alignment Healthcare Inc has demonstrated a reduction in average daily kickouts (ADK) during a period of increased healthcare utilization, highlighting the strength of its technology and operating model. However, the company's approach to value-based care (VBC) faces challenges, such as data friction among various payors and difficulty in achieving consistent outcomes with affiliated primary care providers (PCPs). Additionally, despite reporting above-average EBITDA growth, the valuation multiples for Alignment Healthcare remain elevated compared to peers, which may suggest potential overvaluation concerns amidst these operational challenges.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.